17 January 2020

ASCCT 2018: 7th Annual Meeting

ASCCT 2018: 7th Annual meeting of the American Society for Cellular and Computational Toxicology  

Edited by Erin Hill, David Allen, Kristie Sullivan

Overview of the 7th Annual Meeting of the American Society for Cellular and Computational Toxicology E.L. Berg, D. Allen, K. Sullivan, E. HillIn. Press, Journal Pre-proof, Available online 23 November 2019 (Editorial)

Nonanimal toxicology testing approaches for traditional and deemed tobacco products in a complex regulatory environment: Limitations, possibilities, and future directions Dana Lauterstein, Matthew Savidge, Yanling Chen, Roxana Weil, R. Philip Yeager. February 2020

Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT) G.-E. Costin, E. Hill, J. Brown, A.J. Clippinger. February 2020

Predictive toxicology for regulatory decisions: Implementing new approaches at US Food and Drug Administration Suzanne C. Fitzpatrick, DABT, ERT,US Food and Drug Administration. March 2020

Related content

ESTIV – ASCCT Webinar: NAMs and Medical Devices – Challenges and Successes

We are thrilled to have Kelly Coleman, PhD, DABT, and Lindsey Borton, MPH, DABT…

2026 ESTIV Applied Training Course – the early-bird registration deadline is approaching!

The deadline for the reduced registration fee is approaching fast — 31 July is the last day! 🚨

The ESTIV 2026 Special Issue is open for submissions

Toxicology in Vitro is now accepting manuscripts for the Special Issue arising from the ESTIV 2026 Congress held in Maastricht. The collection takes its direction from the congress theme — “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs” — and is open until 31 December 2026.

Silver Sponsor

Communication partners

Memorandum of Understanding